This statistic shows the top 10 pharmaceutical companies worldwide in 2018, by projected number of originated drugs. For that year, projections said there were 138 such drugs from Swiss-based company Novartis.
Top 10 pharmaceutical companies worldwide by number of originated drugs in 2018*
This statistic shows the top 10 pharmaceutical companies worldwide in 2018, by projected number of originated drugs. For that year, projections said there were 138 such drugs from Swiss-based company Novartis.
Loading statistic...
| Number of originated drugs | |
|---|---|
| Novartis | 138 |
| Pfizer | 126 |
| AstraZeneca | 117 |
| Johnson & Johnson | 116 |
| Roche | 114 |
| GlaxoSmithKline | 111 |
| Merck & Co. | 109 |
| Bristol-Myers Squibb | 96 |
| Takeda | 96 |
| Eli Lilly | 84 |
© Statista 2018
More information
Other interesting statistics
+Research and development in European pharmaceutical industry by country 2016
+Leading 18 European pharmaceutical companies by retail sales 2015
Market share of generics in European countries 2016
+Leading European pharmaceutical & biotechnology companies ranked by market value 2015
+Yearly growth rate of R&D spending in pharmaceutical industry 2003-2017
+VAT rate on prescription-only drugs in Europe 2017
Statista Accounts: Access All Statistics. Starting from $588 / Year
Statistics on "Pharmaceutical trends in Europe"
Popular Related Keywords
- drugs
- origin
- Pharmaceutical companies
- Show more
- pharmaceutical
- drug manufacturers
- research
- drug
- health costs
- R&D
- number
- healthcare
- health expenditure
- research and development
- registered
- phase
- development phases
- pipeline
- pharmaceutical expenditure
- clinical trials
- research and innovation
- health sector
- product pipelines
- research areas
- pharmaceutical manufacturers
- health market
- top
- unregistered
- biopharmaceutical
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Top pharma companies worldwide 2018, by size of R&D pipeline
- Pharma companies worldwide with active R&D pipelines 2001-2018
- Distribution of pharmaceutical R&D companies by region 2018
- Worldwide top origins for pipeline drugs by number of active drugs 2018
- U.S. number of venture capital deals for neurology companies 2006-2017
- Worldwide pipeline drugs by delivery route share 2018
- U.S. psychiatry company IPO financing 2006-2017
- U.S. venture investments in infectious disease companies from 2006 to 2017
- Multiple sclerosis management products in development in the U.S. 2014
- U.S. number of venture capital deals for infectious disease companies 2006-2017
- Market cap of select pharma companies with strong pipeline 2017
- U.S. venture funding of therapeutic companies by disease type 2017
- U.S. number of IPOs for neurology companies 2006-2017
- U.S. infectious disease company IPOs 2006-2017
- Leading MS pharmaceutical drugs in the U.S. by revenue 2013
- Usage rate of top drug classes prescribed to seniors in Canada 2016, by location
- Total Canadian drug spending in Canada by type and finance source 2017
- Overseas cash share of total cash of select US biopharma companies Q3 2017
